Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsNVST -4.14%79 10-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates NVST with a GF Score™ of 79/100 and a GF Value™ of $24.36 (Fairly Valued). The stock has 3 warning signs investors should review. Among 445 Medical Devices & Instruments companies, Envista Holdings ranks worse than 224718.88% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Envista Holdings's current 10-Year Share Buyback Ratio was 0.00%.
NVST's 10-Year Share Buyback Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -3.3 * Ranked among companies with meaningful 10-Year Share Buyback Ratio only.
Envista Holdings (NYSE:NVST) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Envista Holdings 10-Year Share Buyback Ratio Related Terms
NVST vs ICUI, PLSE, MMSI: 10-Year Share Buyback Ratio Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings 10-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Envista Holdings's 10-Year Share Buyback Ratio falls into.
Envista Holdings 10-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of 0.00 mean?
Envista Holdings (NVST) has a 10-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Envista Holdings and its competitors. According to the industry distribution chart, Envista Holdings ranks #999999 out of 445 companies in the Medical Devices & Instruments industry.
Is Envista Holdings' 10-Year Share Buyback Ratio too high?
Envista Holdings' current 10-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Envista Holdings ranks #999999 out of 445 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Envista Holdings has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' 10-Year Share Buyback Ratio compare to ICUI and PLSE?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #999999 out of 445 companies for 10-Year Share Buyback Ratio. This places Envista Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 10-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Envista Holdings and its competitors. Envista Holdings's current 10-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Based on GuruFocus' analysis, Envista Holdings (NVST) is currently considered Fairly Valued. The stock's GF Value™ is $24.36, compared to a current price of $23.94 — trading 1.7% below its estimated fair value. The current 10-Year Share Buyback Ratio is 0.00. Envista Holdings' overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Envista Holdings (NVST), the current 10-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be undervalued.
The current stock price of $23.94 is trading 1.7% below its estimated GF Value™ of $24.36.
GuruFocus considers Envista Holdings to be Fairly Valued.
Key valuation signals for NVST:
10-Year Share Buyback Ratio: 0.00
GF Value™: $24.36 vs. price of $23.94 (1.7% below fair value)
No single metric tells the full story. See the NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
79GF Score
Get the complete analysis for NVST
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVST has been successfully added to your 
